nodes	percent_of_prediction	percent_of_DWPC	metapath
Nevirapine—CYP2A6—Ifosfamide—germ cell cancer	0.203	0.251	CbGbCtD
Nevirapine—CYP2B6—Ifosfamide—germ cell cancer	0.132	0.163	CbGbCtD
Nevirapine—CYP3A5—Ifosfamide—germ cell cancer	0.104	0.129	CbGbCtD
Nevirapine—CYP2C9—Ifosfamide—germ cell cancer	0.0699	0.0862	CbGbCtD
Nevirapine—CYP2B6—Cisplatin—germ cell cancer	0.0644	0.0794	CbGbCtD
Nevirapine—CYP3A5—Etoposide—germ cell cancer	0.0498	0.0615	CbGbCtD
Nevirapine—CYP3A4—Ifosfamide—germ cell cancer	0.0406	0.0501	CbGbCtD
Nevirapine—CYP1A2—Etoposide—germ cell cancer	0.0371	0.0457	CbGbCtD
Nevirapine—CYP2C9—Cisplatin—germ cell cancer	0.034	0.0419	CbGbCtD
Nevirapine—CYP2D6—Vinblastine—germ cell cancer	0.0339	0.0418	CbGbCtD
Nevirapine—CYP3A4—Vinblastine—germ cell cancer	0.0216	0.0266	CbGbCtD
Nevirapine—CYP3A4—Etoposide—germ cell cancer	0.0194	0.024	CbGbCtD
Nevirapine—Pancreatitis—Ifosfamide—germ cell cancer	0.000899	0.00475	CcSEcCtD
Nevirapine—Hepatotoxicity—Methotrexate—germ cell cancer	0.000896	0.00473	CcSEcCtD
Nevirapine—Stevens-Johnson syndrome—Dactinomycin—germ cell cancer	0.000885	0.00467	CcSEcCtD
Nevirapine—Face oedema—Cisplatin—germ cell cancer	0.000883	0.00466	CcSEcCtD
Nevirapine—Necrosis—Methotrexate—germ cell cancer	0.000881	0.00465	CcSEcCtD
Nevirapine—Agranulocytosis—Dactinomycin—germ cell cancer	0.000833	0.0044	CcSEcCtD
Nevirapine—Hyperglycaemia—Ifosfamide—germ cell cancer	0.000827	0.00437	CcSEcCtD
Nevirapine—Aspartate aminotransferase increased—Cisplatin—germ cell cancer	0.000824	0.00435	CcSEcCtD
Nevirapine—Ill-defined disorder—Vinblastine—germ cell cancer	0.000822	0.00434	CcSEcCtD
Nevirapine—Anaemia—Vinblastine—germ cell cancer	0.000818	0.00432	CcSEcCtD
Nevirapine—Stevens-Johnson syndrome—Ifosfamide—germ cell cancer	0.000811	0.00428	CcSEcCtD
Nevirapine—Renal failure—Ifosfamide—germ cell cancer	0.000804	0.00424	CcSEcCtD
Nevirapine—Neuropathy peripheral—Ifosfamide—germ cell cancer	0.000802	0.00423	CcSEcCtD
Nevirapine—Hepatitis—Dactinomycin—germ cell cancer	0.000801	0.00423	CcSEcCtD
Nevirapine—Malaise—Vinblastine—germ cell cancer	0.000799	0.00422	CcSEcCtD
Nevirapine—Conjunctivitis—Ifosfamide—germ cell cancer	0.000795	0.0042	CcSEcCtD
Nevirapine—Pancreatitis—Cisplatin—germ cell cancer	0.000775	0.00409	CcSEcCtD
Nevirapine—Hepatobiliary disease—Ifosfamide—germ cell cancer	0.000774	0.00408	CcSEcCtD
Nevirapine—Bone disorder—Methotrexate—germ cell cancer	0.000766	0.00404	CcSEcCtD
Nevirapine—Agranulocytosis—Ifosfamide—germ cell cancer	0.000763	0.00403	CcSEcCtD
Nevirapine—Erythema multiforme—Dactinomycin—germ cell cancer	0.000758	0.004	CcSEcCtD
Nevirapine—Toxic epidermal necrolysis—Etoposide—germ cell cancer	0.000755	0.00398	CcSEcCtD
Nevirapine—Erythema—Bleomycin—germ cell cancer	0.000748	0.00395	CcSEcCtD
Nevirapine—Discomfort—Vinblastine—germ cell cancer	0.000745	0.00393	CcSEcCtD
Nevirapine—Alanine aminotransferase increased—Etoposide—germ cell cancer	0.000739	0.0039	CcSEcCtD
Nevirapine—Hepatitis—Ifosfamide—germ cell cancer	0.000734	0.00388	CcSEcCtD
Nevirapine—Ulcer—Methotrexate—germ cell cancer	0.000731	0.00386	CcSEcCtD
Nevirapine—Hepatic enzyme increased—Methotrexate—germ cell cancer	0.000731	0.00386	CcSEcCtD
Nevirapine—Connective tissue disorder—Ifosfamide—germ cell cancer	0.000722	0.00381	CcSEcCtD
Nevirapine—Inflammation—Methotrexate—germ cell cancer	0.000713	0.00376	CcSEcCtD
Nevirapine—Thrombocytopenia—Vinblastine—germ cell cancer	0.000708	0.00374	CcSEcCtD
Nevirapine—Erythema—Dactinomycin—germ cell cancer	0.000697	0.00368	CcSEcCtD
Nevirapine—Erythema multiforme—Ifosfamide—germ cell cancer	0.000694	0.00367	CcSEcCtD
Nevirapine—Ill-defined disorder—Bleomycin—germ cell cancer	0.000694	0.00366	CcSEcCtD
Nevirapine—Renal failure—Cisplatin—germ cell cancer	0.000693	0.00366	CcSEcCtD
Nevirapine—Anaemia—Bleomycin—germ cell cancer	0.000691	0.00365	CcSEcCtD
Nevirapine—Neuropathy peripheral—Cisplatin—germ cell cancer	0.000691	0.00365	CcSEcCtD
Nevirapine—Anorexia—Vinblastine—germ cell cancer	0.000689	0.00364	CcSEcCtD
Nevirapine—Conjunctivitis—Cisplatin—germ cell cancer	0.000685	0.00362	CcSEcCtD
Nevirapine—Neutropenia—Etoposide—germ cell cancer	0.000677	0.00358	CcSEcCtD
Nevirapine—Malaise—Bleomycin—germ cell cancer	0.000674	0.00356	CcSEcCtD
Nevirapine—Hepatobiliary disease—Cisplatin—germ cell cancer	0.000667	0.00352	CcSEcCtD
Nevirapine—Immune system disorder—Ifosfamide—germ cell cancer	0.000663	0.0035	CcSEcCtD
Nevirapine—Skin exfoliation—Methotrexate—germ cell cancer	0.00066	0.00349	CcSEcCtD
Nevirapine—Paraesthesia—Vinblastine—germ cell cancer	0.000649	0.00343	CcSEcCtD
Nevirapine—Ill-defined disorder—Dactinomycin—germ cell cancer	0.000647	0.00342	CcSEcCtD
Nevirapine—Anaemia—Dactinomycin—germ cell cancer	0.000645	0.0034	CcSEcCtD
Nevirapine—Stevens-Johnson syndrome—Etoposide—germ cell cancer	0.00064	0.00338	CcSEcCtD
Nevirapine—Erythema—Ifosfamide—germ cell cancer	0.000639	0.00337	CcSEcCtD
Nevirapine—Myalgia—Bleomycin—germ cell cancer	0.000637	0.00336	CcSEcCtD
Nevirapine—Renal failure—Etoposide—germ cell cancer	0.000635	0.00335	CcSEcCtD
Nevirapine—Neuropathy peripheral—Etoposide—germ cell cancer	0.000633	0.00334	CcSEcCtD
Nevirapine—Jaundice—Etoposide—germ cell cancer	0.00063	0.00332	CcSEcCtD
Nevirapine—Discomfort—Bleomycin—germ cell cancer	0.000629	0.00332	CcSEcCtD
Nevirapine—Malaise—Dactinomycin—germ cell cancer	0.000629	0.00332	CcSEcCtD
Nevirapine—Decreased appetite—Vinblastine—germ cell cancer	0.000628	0.00332	CcSEcCtD
Nevirapine—Mouth ulceration—Methotrexate—germ cell cancer	0.000625	0.0033	CcSEcCtD
Nevirapine—Connective tissue disorder—Cisplatin—germ cell cancer	0.000622	0.00328	CcSEcCtD
Nevirapine—Pain—Vinblastine—germ cell cancer	0.000618	0.00326	CcSEcCtD
Nevirapine—Hepatobiliary disease—Etoposide—germ cell cancer	0.000611	0.00323	CcSEcCtD
Nevirapine—Anaphylactic shock—Bleomycin—germ cell cancer	0.00061	0.00322	CcSEcCtD
Nevirapine—Oedema—Bleomycin—germ cell cancer	0.00061	0.00322	CcSEcCtD
Nevirapine—Agranulocytosis—Etoposide—germ cell cancer	0.000603	0.00318	CcSEcCtD
Nevirapine—Thrombocytopenia—Bleomycin—germ cell cancer	0.000598	0.00315	CcSEcCtD
Nevirapine—Feeling abnormal—Vinblastine—germ cell cancer	0.000596	0.00314	CcSEcCtD
Nevirapine—Myalgia—Dactinomycin—germ cell cancer	0.000594	0.00313	CcSEcCtD
Nevirapine—Ill-defined disorder—Ifosfamide—germ cell cancer	0.000593	0.00313	CcSEcCtD
Nevirapine—Gastrointestinal pain—Vinblastine—germ cell cancer	0.000591	0.00312	CcSEcCtD
Nevirapine—Anaemia—Ifosfamide—germ cell cancer	0.000591	0.00312	CcSEcCtD
Nevirapine—Lymphadenopathy—Methotrexate—germ cell cancer	0.000588	0.00311	CcSEcCtD
Nevirapine—Discomfort—Dactinomycin—germ cell cancer	0.000587	0.0031	CcSEcCtD
Nevirapine—Angioedema—Ifosfamide—germ cell cancer	0.000584	0.00308	CcSEcCtD
Nevirapine—Anorexia—Bleomycin—germ cell cancer	0.000582	0.00307	CcSEcCtD
Nevirapine—Malaise—Ifosfamide—germ cell cancer	0.000576	0.00304	CcSEcCtD
Nevirapine—Immune system disorder—Cisplatin—germ cell cancer	0.000572	0.00302	CcSEcCtD
Nevirapine—Abdominal pain—Vinblastine—germ cell cancer	0.000571	0.00302	CcSEcCtD
Nevirapine—Oedema—Dactinomycin—germ cell cancer	0.000569	0.00301	CcSEcCtD
Nevirapine—Hepatic failure—Methotrexate—germ cell cancer	0.000559	0.00295	CcSEcCtD
Nevirapine—Thrombocytopenia—Dactinomycin—germ cell cancer	0.000557	0.00294	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000556	0.00294	CcSEcCtD
Nevirapine—Erythema—Cisplatin—germ cell cancer	0.000551	0.00291	CcSEcCtD
Nevirapine—Erythema multiforme—Etoposide—germ cell cancer	0.000548	0.00289	CcSEcCtD
Nevirapine—Paraesthesia—Bleomycin—germ cell cancer	0.000548	0.00289	CcSEcCtD
Nevirapine—Arthralgia—Ifosfamide—germ cell cancer	0.000544	0.00287	CcSEcCtD
Nevirapine—Myalgia—Ifosfamide—germ cell cancer	0.000544	0.00287	CcSEcCtD
Nevirapine—Anorexia—Dactinomycin—germ cell cancer	0.000543	0.00286	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.00054	0.00285	CcSEcCtD
Nevirapine—Discomfort—Ifosfamide—germ cell cancer	0.000538	0.00284	CcSEcCtD
Nevirapine—Hypersensitivity—Vinblastine—germ cell cancer	0.000532	0.00281	CcSEcCtD
Nevirapine—Dermatitis exfoliative—Methotrexate—germ cell cancer	0.000532	0.00281	CcSEcCtD
Nevirapine—Decreased appetite—Bleomycin—germ cell cancer	0.000531	0.0028	CcSEcCtD
Nevirapine—Immune system disorder—Etoposide—germ cell cancer	0.000524	0.00277	CcSEcCtD
Nevirapine—Pain—Bleomycin—germ cell cancer	0.000522	0.00276	CcSEcCtD
Nevirapine—Oedema—Ifosfamide—germ cell cancer	0.000522	0.00275	CcSEcCtD
Nevirapine—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000522	0.00275	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000519	0.00274	CcSEcCtD
Nevirapine—Asthenia—Vinblastine—germ cell cancer	0.000519	0.00274	CcSEcCtD
Nevirapine—Nervous system disorder—Ifosfamide—germ cell cancer	0.000512	0.0027	CcSEcCtD
Nevirapine—Ill-defined disorder—Cisplatin—germ cell cancer	0.000511	0.0027	CcSEcCtD
Nevirapine—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000511	0.0027	CcSEcCtD
Nevirapine—Anaemia—Cisplatin—germ cell cancer	0.000509	0.00269	CcSEcCtD
Nevirapine—Skin disorder—Ifosfamide—germ cell cancer	0.000507	0.00267	CcSEcCtD
Nevirapine—Feeling abnormal—Bleomycin—germ cell cancer	0.000503	0.00266	CcSEcCtD
Nevirapine—Anorexia—Ifosfamide—germ cell cancer	0.000497	0.00263	CcSEcCtD
Nevirapine—Malaise—Cisplatin—germ cell cancer	0.000497	0.00262	CcSEcCtD
Nevirapine—Decreased appetite—Dactinomycin—germ cell cancer	0.000495	0.00261	CcSEcCtD
Nevirapine—Diarrhoea—Vinblastine—germ cell cancer	0.000494	0.00261	CcSEcCtD
Nevirapine—Fatigue—Dactinomycin—germ cell cancer	0.000491	0.00259	CcSEcCtD
Nevirapine—Pain—Dactinomycin—germ cell cancer	0.000487	0.00257	CcSEcCtD
Nevirapine—Urticaria—Bleomycin—germ cell cancer	0.000485	0.00256	CcSEcCtD
Nevirapine—Body temperature increased—Bleomycin—germ cell cancer	0.000483	0.00255	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000475	0.00251	CcSEcCtD
Nevirapine—Myalgia—Cisplatin—germ cell cancer	0.000469	0.00248	CcSEcCtD
Nevirapine—Feeling abnormal—Dactinomycin—germ cell cancer	0.000469	0.00248	CcSEcCtD
Nevirapine—Paraesthesia—Ifosfamide—germ cell cancer	0.000468	0.00247	CcSEcCtD
Nevirapine—Ill-defined disorder—Etoposide—germ cell cancer	0.000468	0.00247	CcSEcCtD
Nevirapine—Anaemia—Etoposide—germ cell cancer	0.000467	0.00246	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000466	0.00246	CcSEcCtD
Nevirapine—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000465	0.00246	CcSEcCtD
Nevirapine—Somnolence—Ifosfamide—germ cell cancer	0.000464	0.00245	CcSEcCtD
Nevirapine—Liver function test abnormal—Methotrexate—germ cell cancer	0.000464	0.00245	CcSEcCtD
Nevirapine—Discomfort—Cisplatin—germ cell cancer	0.000463	0.00245	CcSEcCtD
Nevirapine—Vomiting—Vinblastine—germ cell cancer	0.000459	0.00243	CcSEcCtD
Nevirapine—Malaise—Etoposide—germ cell cancer	0.000455	0.0024	CcSEcCtD
Nevirapine—Decreased appetite—Ifosfamide—germ cell cancer	0.000453	0.00239	CcSEcCtD
Nevirapine—Headache—Vinblastine—germ cell cancer	0.000453	0.00239	CcSEcCtD
Nevirapine—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	0.000452	0.00239	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.00045	0.00238	CcSEcCtD
Nevirapine—Body temperature increased—Dactinomycin—germ cell cancer	0.00045	0.00238	CcSEcCtD
Nevirapine—Abdominal pain—Dactinomycin—germ cell cancer	0.00045	0.00238	CcSEcCtD
Nevirapine—Fatigue—Ifosfamide—germ cell cancer	0.00045	0.00237	CcSEcCtD
Nevirapine—Anaphylactic shock—Cisplatin—germ cell cancer	0.00045	0.00237	CcSEcCtD
Nevirapine—Oedema—Cisplatin—germ cell cancer	0.00045	0.00237	CcSEcCtD
Nevirapine—Hypersensitivity—Bleomycin—germ cell cancer	0.00045	0.00237	CcSEcCtD
Nevirapine—Pain—Ifosfamide—germ cell cancer	0.000446	0.00235	CcSEcCtD
Nevirapine—Nervous system disorder—Cisplatin—germ cell cancer	0.000441	0.00233	CcSEcCtD
Nevirapine—Thrombocytopenia—Cisplatin—germ cell cancer	0.00044	0.00232	CcSEcCtD
Nevirapine—Asthenia—Bleomycin—germ cell cancer	0.000438	0.00231	CcSEcCtD
Nevirapine—Skin disorder—Cisplatin—germ cell cancer	0.000437	0.00231	CcSEcCtD
Nevirapine—Pruritus—Bleomycin—germ cell cancer	0.000432	0.00228	CcSEcCtD
Nevirapine—Feeling abnormal—Ifosfamide—germ cell cancer	0.00043	0.00227	CcSEcCtD
Nevirapine—Eosinophilia—Methotrexate—germ cell cancer	0.00043	0.00227	CcSEcCtD
Nevirapine—Nausea—Vinblastine—germ cell cancer	0.000429	0.00227	CcSEcCtD
Nevirapine—Anorexia—Cisplatin—germ cell cancer	0.000429	0.00226	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000427	0.00225	CcSEcCtD
Nevirapine—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000427	0.00225	CcSEcCtD
Nevirapine—Pancreatitis—Methotrexate—germ cell cancer	0.000425	0.00225	CcSEcCtD
Nevirapine—Discomfort—Etoposide—germ cell cancer	0.000425	0.00224	CcSEcCtD
Nevirapine—Hypersensitivity—Dactinomycin—germ cell cancer	0.000419	0.00221	CcSEcCtD
Nevirapine—Urticaria—Ifosfamide—germ cell cancer	0.000414	0.00219	CcSEcCtD
Nevirapine—Body temperature increased—Ifosfamide—germ cell cancer	0.000412	0.00218	CcSEcCtD
Nevirapine—Abdominal pain—Ifosfamide—germ cell cancer	0.000412	0.00218	CcSEcCtD
Nevirapine—Anaphylactic shock—Etoposide—germ cell cancer	0.000412	0.00218	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.00041	0.00216	CcSEcCtD
Nevirapine—Asthenia—Dactinomycin—germ cell cancer	0.000408	0.00216	CcSEcCtD
Nevirapine—Neutropenia—Methotrexate—germ cell cancer	0.000406	0.00214	CcSEcCtD
Nevirapine—Paraesthesia—Cisplatin—germ cell cancer	0.000404	0.00213	CcSEcCtD
Nevirapine—Thrombocytopenia—Etoposide—germ cell cancer	0.000403	0.00213	CcSEcCtD
Nevirapine—Skin disorder—Etoposide—germ cell cancer	0.0004	0.00211	CcSEcCtD
Nevirapine—Anorexia—Etoposide—germ cell cancer	0.000393	0.00207	CcSEcCtD
Nevirapine—Decreased appetite—Cisplatin—germ cell cancer	0.000391	0.00206	CcSEcCtD
Nevirapine—Diarrhoea—Dactinomycin—germ cell cancer	0.000389	0.00206	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000388	0.00205	CcSEcCtD
Nevirapine—Vomiting—Bleomycin—germ cell cancer	0.000388	0.00205	CcSEcCtD
Nevirapine—Rash—Bleomycin—germ cell cancer	0.000385	0.00203	CcSEcCtD
Nevirapine—Pain—Cisplatin—germ cell cancer	0.000385	0.00203	CcSEcCtD
Nevirapine—Dermatitis—Bleomycin—germ cell cancer	0.000384	0.00203	CcSEcCtD
Nevirapine—Hypersensitivity—Ifosfamide—germ cell cancer	0.000384	0.00203	CcSEcCtD
Nevirapine—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.000384	0.00203	CcSEcCtD
Nevirapine—Renal failure—Methotrexate—germ cell cancer	0.00038	0.00201	CcSEcCtD
Nevirapine—Conjunctivitis—Methotrexate—germ cell cancer	0.000376	0.00199	CcSEcCtD
Nevirapine—Asthenia—Ifosfamide—germ cell cancer	0.000374	0.00198	CcSEcCtD
Nevirapine—Feeling abnormal—Cisplatin—germ cell cancer	0.000371	0.00196	CcSEcCtD
Nevirapine—Paraesthesia—Etoposide—germ cell cancer	0.00037	0.00195	CcSEcCtD
Nevirapine—Pruritus—Ifosfamide—germ cell cancer	0.000369	0.00195	CcSEcCtD
Nevirapine—Somnolence—Etoposide—germ cell cancer	0.000366	0.00193	CcSEcCtD
Nevirapine—Hepatobiliary disease—Methotrexate—germ cell cancer	0.000366	0.00193	CcSEcCtD
Nevirapine—Nausea—Bleomycin—germ cell cancer	0.000363	0.00191	CcSEcCtD
Nevirapine—Vomiting—Dactinomycin—germ cell cancer	0.000362	0.00191	CcSEcCtD
Nevirapine—Agranulocytosis—Methotrexate—germ cell cancer	0.000361	0.00191	CcSEcCtD
Nevirapine—Rash—Dactinomycin—germ cell cancer	0.000359	0.00189	CcSEcCtD
Nevirapine—Decreased appetite—Etoposide—germ cell cancer	0.000358	0.00189	CcSEcCtD
Nevirapine—Diarrhoea—Ifosfamide—germ cell cancer	0.000357	0.00188	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000356	0.00188	CcSEcCtD
Nevirapine—Body temperature increased—Cisplatin—germ cell cancer	0.000356	0.00188	CcSEcCtD
Nevirapine—Fatigue—Etoposide—germ cell cancer	0.000355	0.00188	CcSEcCtD
Nevirapine—Pain—Etoposide—germ cell cancer	0.000352	0.00186	CcSEcCtD
Nevirapine—Hepatitis—Methotrexate—germ cell cancer	0.000347	0.00183	CcSEcCtD
Nevirapine—Feeling abnormal—Etoposide—germ cell cancer	0.00034	0.00179	CcSEcCtD
Nevirapine—Nausea—Dactinomycin—germ cell cancer	0.000338	0.00179	CcSEcCtD
Nevirapine—Gastrointestinal pain—Etoposide—germ cell cancer	0.000337	0.00178	CcSEcCtD
Nevirapine—Vomiting—Ifosfamide—germ cell cancer	0.000332	0.00175	CcSEcCtD
Nevirapine—Hypersensitivity—Cisplatin—germ cell cancer	0.000331	0.00175	CcSEcCtD
Nevirapine—Rash—Ifosfamide—germ cell cancer	0.000329	0.00174	CcSEcCtD
Nevirapine—Dermatitis—Ifosfamide—germ cell cancer	0.000329	0.00173	CcSEcCtD
Nevirapine—Erythema multiforme—Methotrexate—germ cell cancer	0.000328	0.00173	CcSEcCtD
Nevirapine—Urticaria—Etoposide—germ cell cancer	0.000327	0.00173	CcSEcCtD
Nevirapine—Body temperature increased—Etoposide—germ cell cancer	0.000326	0.00172	CcSEcCtD
Nevirapine—Abdominal pain—Etoposide—germ cell cancer	0.000326	0.00172	CcSEcCtD
Nevirapine—Asthenia—Cisplatin—germ cell cancer	0.000323	0.0017	CcSEcCtD
Nevirapine—Immune system disorder—Methotrexate—germ cell cancer	0.000314	0.00166	CcSEcCtD
Nevirapine—Nausea—Ifosfamide—germ cell cancer	0.00031	0.00164	CcSEcCtD
Nevirapine—Diarrhoea—Cisplatin—germ cell cancer	0.000308	0.00162	CcSEcCtD
Nevirapine—Hypersensitivity—Etoposide—germ cell cancer	0.000304	0.0016	CcSEcCtD
Nevirapine—Erythema—Methotrexate—germ cell cancer	0.000302	0.0016	CcSEcCtD
Nevirapine—Asthenia—Etoposide—germ cell cancer	0.000296	0.00156	CcSEcCtD
Nevirapine—Pruritus—Etoposide—germ cell cancer	0.000291	0.00154	CcSEcCtD
Nevirapine—Vomiting—Cisplatin—germ cell cancer	0.000286	0.00151	CcSEcCtD
Nevirapine—Rash—Cisplatin—germ cell cancer	0.000284	0.0015	CcSEcCtD
Nevirapine—Dermatitis—Cisplatin—germ cell cancer	0.000283	0.0015	CcSEcCtD
Nevirapine—Diarrhoea—Etoposide—germ cell cancer	0.000282	0.00149	CcSEcCtD
Nevirapine—Ill-defined disorder—Methotrexate—germ cell cancer	0.000281	0.00148	CcSEcCtD
Nevirapine—Anaemia—Methotrexate—germ cell cancer	0.000279	0.00148	CcSEcCtD
Nevirapine—Malaise—Methotrexate—germ cell cancer	0.000273	0.00144	CcSEcCtD
Nevirapine—Nausea—Cisplatin—germ cell cancer	0.000267	0.00141	CcSEcCtD
Nevirapine—Vomiting—Etoposide—germ cell cancer	0.000262	0.00138	CcSEcCtD
Nevirapine—Rash—Etoposide—germ cell cancer	0.00026	0.00137	CcSEcCtD
Nevirapine—Dermatitis—Etoposide—germ cell cancer	0.00026	0.00137	CcSEcCtD
Nevirapine—Headache—Etoposide—germ cell cancer	0.000258	0.00136	CcSEcCtD
Nevirapine—Myalgia—Methotrexate—germ cell cancer	0.000257	0.00136	CcSEcCtD
Nevirapine—Arthralgia—Methotrexate—germ cell cancer	0.000257	0.00136	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000256	0.00135	CcSEcCtD
Nevirapine—Discomfort—Methotrexate—germ cell cancer	0.000254	0.00134	CcSEcCtD
Nevirapine—Anaphylactic shock—Methotrexate—germ cell cancer	0.000247	0.0013	CcSEcCtD
Nevirapine—Nausea—Etoposide—germ cell cancer	0.000245	0.00129	CcSEcCtD
Nevirapine—Nervous system disorder—Methotrexate—germ cell cancer	0.000242	0.00128	CcSEcCtD
Nevirapine—Thrombocytopenia—Methotrexate—germ cell cancer	0.000242	0.00128	CcSEcCtD
Nevirapine—Skin disorder—Methotrexate—germ cell cancer	0.00024	0.00127	CcSEcCtD
Nevirapine—Anorexia—Methotrexate—germ cell cancer	0.000235	0.00124	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000225	0.00119	CcSEcCtD
Nevirapine—Paraesthesia—Methotrexate—germ cell cancer	0.000222	0.00117	CcSEcCtD
Nevirapine—Somnolence—Methotrexate—germ cell cancer	0.000219	0.00116	CcSEcCtD
Nevirapine—Decreased appetite—Methotrexate—germ cell cancer	0.000215	0.00113	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000213	0.00112	CcSEcCtD
Nevirapine—Fatigue—Methotrexate—germ cell cancer	0.000213	0.00112	CcSEcCtD
Nevirapine—Pain—Methotrexate—germ cell cancer	0.000211	0.00111	CcSEcCtD
Nevirapine—Feeling abnormal—Methotrexate—germ cell cancer	0.000203	0.00107	CcSEcCtD
Nevirapine—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000202	0.00107	CcSEcCtD
Nevirapine—Urticaria—Methotrexate—germ cell cancer	0.000196	0.00103	CcSEcCtD
Nevirapine—Abdominal pain—Methotrexate—germ cell cancer	0.000195	0.00103	CcSEcCtD
Nevirapine—Body temperature increased—Methotrexate—germ cell cancer	0.000195	0.00103	CcSEcCtD
Nevirapine—Hypersensitivity—Methotrexate—germ cell cancer	0.000182	0.00096	CcSEcCtD
Nevirapine—Asthenia—Methotrexate—germ cell cancer	0.000177	0.000935	CcSEcCtD
Nevirapine—Pruritus—Methotrexate—germ cell cancer	0.000175	0.000922	CcSEcCtD
Nevirapine—Diarrhoea—Methotrexate—germ cell cancer	0.000169	0.000891	CcSEcCtD
Nevirapine—Vomiting—Methotrexate—germ cell cancer	0.000157	0.000828	CcSEcCtD
Nevirapine—Rash—Methotrexate—germ cell cancer	0.000156	0.000821	CcSEcCtD
Nevirapine—Dermatitis—Methotrexate—germ cell cancer	0.000155	0.000821	CcSEcCtD
Nevirapine—Headache—Methotrexate—germ cell cancer	0.000155	0.000816	CcSEcCtD
Nevirapine—Nausea—Methotrexate—germ cell cancer	0.000147	0.000774	CcSEcCtD
